Background pharmacological therapy in the ANTHEM‐HF: comparison to contemporary trials of novel heart failure therapies

AIMS: Clinical trials of new heart failure (HF) therapies administer guideline‐directed medical therapy (GDMT) as background pharmacologic treatment (BPT). In the ANTHEM‐HF Pilot Study, addition of autonomic regulation therapy to GDMT significantly improved left ventricular function, New York Heart...

Descripción completa

Detalles Bibliográficos
Autores principales: Premchand, Rajendra K., Sharma, Kamal, Mittal, Sanjay, Monteiro, Rufino, Libbus, Imad, Ardell, Jeffrey L., Gregory, Douglas D., KenKnight, Bruce H., Amurthur, Badri, DiCarlo, Lorenzo A., Anand, Inder S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816059/
https://www.ncbi.nlm.nih.gov/pubmed/31339232
http://dx.doi.org/10.1002/ehf2.12484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816059/
https://www.ncbi.nlm.nih.gov/pubmed/31339232
http://dx.doi.org/10.1002/ehf2.12484

Ejemplares similares